doi: 10.1007/s00108-002-0558-0.
[Status of pharmacogenomics and its future role in drug therapy]
[Article in German]
Affiliations
- PMID:12053407
- DOI: 10.1007/s00108-002-0558-0
Item in Clipboard
[Status of pharmacogenomics and its future role in drug therapy]
[Article in German]
I Cascorbi. Internist (Berl).2002 Apr.
Display options
Format
Display options
Format
No abstract available
Similar articles
- [Individualization of drug therapy and pharmacogenetics].Yamamoto I, Azuma J.Yamamoto I, et al.Nihon Rinsho. 1998 Mar;56(3):579-83.Nihon Rinsho. 1998.PMID:9549339Review.Japanese.
- Phenotyping of drug metabolism in infants and children: potentials and problems.Rane A.Rane A.Pediatrics. 1999 Sep;104(3 Pt 2):640-3.Pediatrics. 1999.PMID:10469807No abstract available.
- [Genetic polymorphisms of drug metabolizing enzymes].Fujieda M, Yamazaki H, Kamataki T.Fujieda M, et al.Gan To Kagaku Ryoho. 2002 May;29(5):663-8.Gan To Kagaku Ryoho. 2002.PMID:12040668Review.Japanese.
- Pharmacogenetics of CYP2C subfamily in a Japanese population.Ieiri I, Higuchi S.Ieiri I, et al.J Toxicol Sci. 1998 Jul;23 Suppl 2:129-31. doi: 10.2131/jts.23.supplementii_129.J Toxicol Sci. 1998.PMID:9760448Review.No abstract available.
- Increasing relevance of pharmacogenetics of drug metabolism in clinical practice.Pillans PI.Pillans PI.Intern Med J. 2001 Nov;31(8):476-8. doi: 10.1046/j.1445-5994.2001.00108.x.Intern Med J. 2001.PMID:11720061Review.
Cited by
- [Oncologic pharmacotherapy of elderly patients].Wedding U, Merkel U, Farker K, Höffken K.Wedding U, et al.Internist (Berl). 2003 Aug;44(8):977-85. doi: 10.1007/s00108-003-0943-3.Internist (Berl). 2003.PMID:14671812Review.German.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical